Ritlecitinib tosylate
4-methylbenzenesulfonic acid;1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)piperidin-1-yl]prop-2-en-1-one
Molecular Identity
Ritlecitinib tosylate
4-methylbenzenesulfonic acid;1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)piperidin-1-yl]prop-2-en-1-one
PubChem CID: 145722621
Ritlecitinib tosylate is an organosulfonate salt obtained by combining equimolar amounts of ritlecitinib and 4-toluenesulfonic acid. It is a kinase inhibitor, developed by Pfizer for the treatment of severe alopecia areata in adults and adolescents 12 years and older. It has a role as an anti-inflammatory drug, an immunosuppressive agent, an antirheumatic drug, a dermatologic drug and an EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor. It contains a ritlecitinib(1+).
2D Structure
Properties
C22H27N5O4S
Molecular Formula
457.50
Molecular Weight
g/mol
457.1784
Exact Mass
Da
137
TPSA
Good oral absorption (< 140 A²)
3
H-Bond Donors
7
H-Bond Acceptors
608
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
Ritlecitinib tosylate2192215-81-7Ritlecitinib toslatePF-06651600 tosylateLitfuloEAG4T1459KUNII-EAG4T1459KRefChem:57735RITLECITINIB TOSILATERitlecitinib (tosylate)Ritlecitinib tosilate (JAN)RITLECITINIB TOSILATE [JAN]Litfulo (TN)Ritlecitinib tosylate (USAN)orb1739658
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Ritlecitinib tosylate
Loading drug network...